{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:59:03Z","timestamp":1790402343316,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The Global Polio Eradication Initiative (GPEI), launched in 1988, has successfully reduced wild poliovirus (WPV) cases by over 99.9%, with WPV type 2 and WPV3 declared eradicated in 2015 and 2019, respectively. However, as of 2024, WPV1 remains endemic in Afghanistan and Pakistan. Since 2000, outbreaks of circulating virus derived of polio vaccines (cVDPVs) have emerged in multiple regions, primary driven by low vaccine coverage rates (VCRs). The COVID-19 pandemic disrupted routine immunization, resulting in millions of unvaccinated children, and leaving many countries vulnerable to both WPV1 and cVDPVs outbreaks. This paper reviews the epidemiological landscape of poliomyelitis post the COVID-19 pandemic, and the strategies and challenges to achieve the global polio eradication.<\/jats:p>","DOI":"10.3390\/vaccines12121323","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:40:32Z","timestamp":1732606832000},"page":"1323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Polio Epidemiology: Strategies and Challenges for Polio Eradication Post the COVID-19 Pandemic"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9562-4796","authenticated-orcid":false,"given":"Lucia F.","family":"Bricks","sequence":"first","affiliation":[{"name":"Sanofi Vaccines Medical, Av Na\u00e7\u00f5es Unidas, S\u00e3o Paulo 14401, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5342-7038","authenticated-orcid":false,"given":"Denis","family":"Macina","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines Medical, 14 Espace Henri Vallee, 69007 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-7046","authenticated-orcid":false,"given":"Juan C.","family":"Vargas-Zambrano","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines Medical, 14 Espace Henri Vallee, 69007 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"ref_1","unstructured":"(2024, July 25). Poliomyelitis. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/poliomyelitis."},{"key":"ref_2","unstructured":"(2024, October 24). AFP\/Polio Data. Available online: https:\/\/extranet.who.int\/polis\/public\/CaseCount.aspx."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cavestany, R.L., Eisenhawer, M., Diop, O.M., Verma, H., Quddus, A., and Mach, O. (2024). The Last Mile in Polio Eradication: Program Challenges and Perseverance. Pathogens, 13.","DOI":"10.3390\/pathogens13040323"},{"key":"ref_4","unstructured":"Polioeradication (2024, October 24). Global wild AFP and Environmental Samples, 2018\u20132024. Available online: https:\/\/polioeradication.org\/wild-poliovirus-count\/."},{"key":"ref_5","unstructured":"Polioeradication (2024, October 21). Global Circulation Vaccine Derived (cVDPV) AFP and Environmental Samples, 2021\u20132024. Available online: https:\/\/polioeradication.org\/wild-poliovirus-count\/."},{"key":"ref_6","unstructured":"(2024, September 04). Vaccination and Immunization Statistics\u2014UNICEF DATA. Available online: https:\/\/data.unicef.org\/resources\/immunization-coverage-estimates-data-visualization\/."},{"key":"ref_7","unstructured":"(2024, July 24). Polio (Pol3) Immunization Coverage Among 1-Year-Olds (%). Available online: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/polio-(pol3)-immunization-coverage-among-1-year-olds-(-)."},{"key":"ref_8","unstructured":"Plotkin, S., Orenstein, W.A., and Offit, P. (2018). Poliovirus vaccine live. Plotkin\u2019s Vaccines, Elsevier. [7th ed.]."},{"key":"ref_9","unstructured":"Plotkin, S., Orenstein, W.A., and Offit, P. (2018). Poliovirus vaccine inactivated. Plotkin\u2019s Vaccines, Elsevier. [7th ed.]."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Muslin, C., Mac Kain, A., Bessaud, M., Blondel, B., and Delpeyroux, F. (2019). Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process. Viruses, 11.","DOI":"10.3390\/v11090859"},{"key":"ref_11","unstructured":"(2024, July 29). Vaccination Schedule for Poliomyelitis. Available online: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/vaccination-schedule-for-poliomyelitis."},{"key":"ref_12","unstructured":"(2024, July 26). Update on Wild Poliovirus Type 1 Outbreak\u2014Southeastern Africa, 2021\u20132022 MMWR, Available online: https:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7215a3.htm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15585\/mmwr.mm7319a4","article-title":"Progress Toward Poliomyelitis Eradication\u2014Worldwide, January 2022\u2013December 2023","volume":"73","author":"Geiger","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_14","unstructured":"(2024, July 24). Statement Following the Thirty-Eighth Meeting of the IHR Emergency Committee for Polio. Available online: https:\/\/www.who.int\/news\/item\/08-04-2024-statement-following-the-thirty-eighth-meeting-of-the-ihr-emergency-committee-for-polio."},{"key":"ref_15","unstructured":"(2024, July 25). GPEI Press Release on nOPV2 Prequalification\u2014GPEI. Available online: https:\/\/polioeradication.org\/news\/gpei-press-release-on-nopv2-prequalification\/."},{"key":"ref_16","unstructured":"(2024, July 27). GPEI Statement on cVDPV2 detections in Burundi and Democratic Republic of the Congo. Available online: https:\/\/polioeradication.org\/news-post\/gpei-statement-on-cvdpv2-detections-in-burundi-and-democratic-republic-of-the-congo."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm7341a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks\u2014Worldwide, January 2023\u2013June 2024","volume":"73","author":"Greene","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_18","unstructured":"(2024, July 24). Variant Type 2 Poliovirus Isolated from Sewage Samples in Gaza\u2014GPEI. Available online: https:\/\/polioeradication.org\/news\/variant-type-2-poliovirus-isolated-from-sewage-samples-in-gaza\/."},{"key":"ref_19","unstructured":"(2024, September 11). Statement of the Thirty-Ninth Meeting of the Polio IHR Emergency Committee. Available online: https:\/\/www.who.int\/news\/item\/13-08-2024-statement-of-the-thirty-ninth-meeting-of-the-polio-ihr-emergency-committee."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4067\/S0716-10182020000600701","article-title":"Estado actual de la poliomielitis en Latinoam\u00e9rica","volume":"37","author":"Ayala","year":"2020","journal-title":"Rev. Chil. Infectologia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(20)30213-0","article-title":"The case for replacing live oral polio vaccine with inactivated vaccine in the Americas","volume":"395","author":"Fitzpatrick","year":"2020","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.15585\/mmwr.mm6928a4","article-title":"Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses\u2014Worldwide, July 2018\u2013December 2019","volume":"69","author":"Macklin","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_23","unstructured":"Pan American Health Organization, and World Health Organization (2024, September 26). Epidemiological Update: Poliomyelitis in the Region of the Americas, Available online: https:\/\/www.paho.org\/en\/documents\/epidemiological-update-poliomyelitis-region-americas-23-march-2023."},{"key":"ref_24","first-page":"1524","article-title":"Response to Vaccine-Derived Polioviruses Detected through Environmental Surveillance, Guatemala, 2019","volume":"29","author":"Cajas","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e28668","DOI":"10.1002\/jmv.28668","article-title":"Dynamic changes in polioviruses identified by environmental surveillance in Guangzhou, 2009\u20132021","volume":"95","author":"Chen","year":"2023","journal-title":"J. Med Virol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Al-Qassimi, M.A., Al Amad, M., Al-Dar, A., Al Sakaf, E., Al Hadad, A., and Raja\u2019a, Y.A. (2024). Circulating vaccine derived polio virus type 2 outbreak and response in Yemen, 2021\u20132022, a retrospective descriptive analysis. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09215-1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(21)00453-9","article-title":"Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: A retrospective analysis of surveillance data for 51 countries in Africa","volume":"22","author":"Cooper","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14740338.2024.2359616","article-title":"Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: Disproportionality analysis using VAERS and systematic review","volume":"23","author":"Suares","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mohanty, M.C., Govindaraj, G., Ahmad, M., Varose, S.Y., Tatkare, M., Shete, A., Yadav, S., Joshi, Y., Yadav, P., and Sharma, D. (2024). Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Excretion in an Infant with Severe Combined Immune Deficiency with Spillover to a Parent. Vaccines, 12.","DOI":"10.3390\/vaccines12070759"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"199177","DOI":"10.1016\/j.virusres.2023.199177","article-title":"Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China","volume":"334","author":"Guo","year":"2023","journal-title":"Virus Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E10625","DOI":"10.1073\/pnas.1808798115","article-title":"Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data","volume":"115","author":"Brouwer","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"A142","DOI":"10.1016\/j.vaccine.2022.10.060","article-title":"Outbreak response strategies with type 2-containing oral poliovirus vaccines","volume":"41","author":"Kalkowska","year":"2023","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2023.04.037","article-title":"Outbreak management strategies for cocirculation of multiple poliovirus types","volume":"41","author":"Kalkowska","year":"2023","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/risa.14158","article-title":"Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences","volume":"44","author":"Kalkowska","year":"2024","journal-title":"Risk Anal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41385-021-00428-0","article-title":"Mucosal immunity to poliovirus","volume":"15","author":"Connor","year":"2021","journal-title":"Mucosal Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/jiae006","article-title":"Mucosal Immunity to Poliovirus in Children 0\u201315 Years of Age: A Community-Based Study in Karachi, Pakistan in 2019","volume":"230","author":"Saleem","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Habib, M.A., Soofi, S.B., Hussain, I., Ahmed, I., Hussain, Z., Tahir, R., Anwar, S., Cousens, S., and Bhutta, Z.A. (2023). Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan. Vaccines, 11.","DOI":"10.20944\/preprints202306.1867.v1"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1473-3099(23)00505-4","article-title":"Use of inactivated poliovirus vaccine for poliovirus outbreak response","volume":"24","author":"Bandyopadhyay","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Devaux, C.A., Pontarotti, P., Levasseur, A., Colson, P., and Raoult, D. (2024). Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1284337"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1016\/S2214-109X(23)00116-X","article-title":"Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: A clustered, population-based seroprevalence survey","volume":"11","author":"Kennedy","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(23)00688-6","article-title":"Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: A case-control study","volume":"24","author":"Cooper","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ivanova, O.E., Eremeeva, T.P., Baykova, O.Y., Krasota, A.Y., Yakovchuk, E.V., Shustova, E.Y., Malyshkina, L.P., Mustafina, A.N.-I., Mikhailova, Y.M., and Chirova, A.V. (2024). Detection of Polioviruses Type 2 among Migrant Children Arriving to the Russian Federation from a Country with a Registered Poliomyelitis Outbreak. Vaccines, 12.","DOI":"10.3390\/vaccines12070718"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jiab480","article-title":"Waning Immunity After Receipt of Pertussis, Diphtheria, Tetanus, and Polio-Related Vaccines: A Systematic Review and Meta-analysis","volume":"225","author":"Gao","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Larocca, A.M.V., Bianchi, F.P., Bozzi, A., Tafuri, S., Stefanizzi, P., and Germinario, C.A. (2022). Long-Term Immunogenicity of Inactivated and Oral Polio Vaccines: An Italian Retrospective Cohort Study. Vaccines, 10.","DOI":"10.3390\/vaccines10081329"},{"key":"ref_45","first-page":"2644","article-title":"Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study","volume":"14","author":"Tan","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e21298","DOI":"10.1097\/MD.0000000000021298","article-title":"Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Alfonso, V.H., Voorman, A., Hoff, N.A., Weldon, W.C., Gerber, S., Gadoth, A., Halbrook, M., Goldsmith, A., Mukadi, P., and Doshi, R.H. (2022). Poliovirus immunity among adults in the Democratic Republic of the Congo: A cross-sectional serosurvey. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-021-06951-6"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13312-024-3166-4","article-title":"Novel OPV is Still not the Right Tool for Polio Eradication","volume":"61","author":"John","year":"2024","journal-title":"Indian Pediatr."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Fine, P.E.M. (2024). Population Immunity and Polio Eradication. Pathogens, 13.","DOI":"10.3390\/pathogens13030183"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sutter, R.W., Eisenhawer, M., Molodecky, N.A., Verma, H., and Okayasu, H. (2024). Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance. Pathogens, 13.","DOI":"10.3390\/pathogens13030224"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/23744235.2024.2392791","article-title":"The respiratory route of transmission of virulent polioviruses","volume":"56","author":"John","year":"2024","journal-title":"Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/10105395231158866","article-title":"The History and Current Killings of Polio Vaccinators in Pakistan: A Need for Targeted Surveillance Strategy","volume":"35","author":"Wahid","year":"2023","journal-title":"Asia Pac. J. Public Health"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Abbasi, F.H., Shaikh, A.A., Mehraj, J., Raza, S.M., Rasool, S., Bullo, U.F., Mehraj, S., Phul, Z.A., Sahitia, S., and Zardari, A.A. (2022). Vaccine Hesitancy and Perceptions of the Community about Polio in High-Risk Areas of Karachi, Sindh, Pakistan. Vaccines, 11.","DOI":"10.3390\/vaccines11010070"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4269\/ajtmh.23-0319","article-title":"Oral and Inactivated Polio Vaccine Coverage and Determinants of Coverage Inequality Among the Most At-Risk Populations in Ethiopia","volume":"109","author":"Gebremedhin","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Jacobson, A., Spitzer, S., Gorelik, Y., and Edelstein, M. (2023). Barriers and enablers to vaccination in the ultra-orthodox Jewish population: A systematic review. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1244368"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.15585\/mmwr.mm7249a3","article-title":"Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"72","author":"Kidd","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/12\/1323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:39:46Z","timestamp":1760114386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/12\/1323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["vaccines12121323"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12121323","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}